Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperimmune Plasma in COVID-19 Pneumonia
NCT04366245Phase 2Completed
- Sponsor
- Red Andaluza de Terapias Avanzadas
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Red Andaluza de Terapias Avanzadas. Started Apr 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04366245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366245.